Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Clinical Study to Evaluate the Safety and Efficacy of ProvayBlueTM (Methylene Blue) for the Treatment of Acquired Methemoglobinemia

NCT03395223 is registered in ClinicalTrials.gov with Provepharm SAS as lead sponsor.

NCT NCT03395223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Clinical Study to Evaluate the Safety and Efficacy of ProvayBlueTM (Methylene Blue) for the Treatment of Acquired Methemoglobinemia
Lead sponsor
Provepharm SAS
Phase
Phase 4
Overall status
Completed
Start date
July 6, 2018
Completion date
August 31, 2020
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired methaemoglobinaemia